China is signaling a major push to secure more natural gas from Russia, raising curiosity and attention in global energy markets. The country’s draft five-year plan has included references to two key ...

The pseudomonal infections clinical trial analysis report delivers important insights into ongoing research of 10+ pipeline ...

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today announced corporate priorities and ...

Workforce demand data central to next Pipeline, giving investors and industry a clearer view to support long-term planning for skills and investment ...

Cash, cash equivalents and marketable securities expected to support operations into the third quarter of 2027 WATERTOWN, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (NMRA), a ...

Compelling Phase 1 Data for SEP-631 (MRGPRX2 NAM) in Healthy Volunteers Support Phase 2b Development, Initially in Chronic Spontaneous Urticaria (CSU) in Second Half of 2026 Advancing SEP-479 (PTH1R ...

NVIDIA Corporation (NASDAQ:NVDA) ranks among the best FAANG+ stocks to invest in right now. On March 9, BofA Securities restated its Buy rating on NVIDIA Corporation (NASDAQ:NVDA) and set a $300 price ...

Roivant enters new phase of corporate journey with 3+ launches, 4+ NDA/BLA filings, 8+ pivotal and 3+ proof-of-concept study readouts expected over the next three years Highlighting clinical execution ...

Q4 2025 net product revenues of $54.3 million; 2025 full-year net product revenues of $227.3 million, representing a 49% increase over 2024 full-year net product revenues Expect significant Vafseo ® ...